<code id='50C3B1E1D2'></code><style id='50C3B1E1D2'></style>
    • <acronym id='50C3B1E1D2'></acronym>
      <center id='50C3B1E1D2'><center id='50C3B1E1D2'><tfoot id='50C3B1E1D2'></tfoot></center><abbr id='50C3B1E1D2'><dir id='50C3B1E1D2'><tfoot id='50C3B1E1D2'></tfoot><noframes id='50C3B1E1D2'>

    • <optgroup id='50C3B1E1D2'><strike id='50C3B1E1D2'><sup id='50C3B1E1D2'></sup></strike><code id='50C3B1E1D2'></code></optgroup>
        1. <b id='50C3B1E1D2'><label id='50C3B1E1D2'><select id='50C3B1E1D2'><dt id='50C3B1E1D2'><span id='50C3B1E1D2'></span></dt></select></label></b><u id='50C3B1E1D2'></u>
          <i id='50C3B1E1D2'><strike id='50C3B1E1D2'><tt id='50C3B1E1D2'><pre id='50C3B1E1D2'></pre></tt></strike></i>

          explore

          explore

          author:focus    Page View:1572

          Editor’s note: A livestream of the event is embedded below.

          Enough talk about fairness, safety, and effectiveness. If we want AI systems to possess these attributes in health care, we have to test them with those goals in mind.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Congress might make insulin pumps more accessible to the blind
          Congress might make insulin pumps more accessible to the blind

          AdobeKatieKeimwasdiagnosedwithtype1diabetesin1967whenshewaseight,wellbeforetheeraofinsulinpumpsoreve

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

          CDCWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyour